{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:52:14Z","timestamp":1778028734343,"version":"3.51.4"},"reference-count":15,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T00:00:00Z","timestamp":1630022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000761","name":"Imperial College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medical Genetics"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.ejmg.2021.104312","type":"journal-article","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T11:42:33Z","timestamp":1629114153000},"page":"104312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["DNA variant classification\u2013reconsidering \u201callele rarity\u201d and \u201cphenotype\u201d criteria in ACMG\/AMP guidelines"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9801-8094","authenticated-orcid":false,"given":"Connor D.","family":"Davieson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie E.","family":"Joyce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3509-6140","authenticated-orcid":false,"given":"Lakshya","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9007-5775","authenticated-orcid":false,"given":"Claire L.","family":"Shovlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejmg.2021.104312_bib1","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ajhg.2020.09.011","article-title":"Variant classification concordance using the ACMG-AMP variant interpretation guidelines across nine genomic implementation research studies","volume":"107","author":"Amendola","year":"2020","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.ejmg.2021.104312_bib2","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.ajhg.2019.02.025","article-title":"The responsibility to recontact research participants after reinterpretation of genetic and genomic research results","volume":"104","author":"Bombard","year":"2019","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.ejmg.2021.104312_bib3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13023-018-0982-4","article-title":"Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia","volume":"14","author":"Buscarini","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.ejmg.2021.104312_bib4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41431-018-0285-1","article-title":"Recontacting patients in clinical genetics services: recommendations of the European Society of Human Genetics","volume":"27","author":"Carrieri","year":"2019","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ejmg.2021.104312_bib5","unstructured":"ClinGen Sequence Variant Interpretation Recommendation for PM2 - Version 1.0, Working Group Page: https:\/\/clinicalgenome.org\/working-groups\/sequence-variant-interpretation\/, Date Approved: September 4, 2020."},{"issue":"1","key":"10.1016\/j.ejmg.2021.104312_bib6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/bloodadvances.2020003264","article-title":"ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease","volume":"5","author":"Connell","year":"2021","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.ejmg.2021.104312_bib7","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41436-018-0391-z","article-title":"Patient re-contact after revision of genomic test results: points to consider-a statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"21","author":"David","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.ejmg.2021.104312_bib17","series-title":"ACGS Best Practice Guidelines for Variant Classification in Rare Disease 2020","author":"Ellard","year":"2020"},{"issue":"7809","key":"10.1016\/j.ejmg.2021.104312_bib10","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"Genome Aggregation Database Consortium, Neale BM, Daly MJ, MacArthur DG. The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.ejmg.2021.104312_bib11","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41580-019-0126-2","article-title":"Quality and quantity control of gene expression by nonsense-mediated mRNA decay","volume":"20","author":"Kurosaki","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"D1","key":"10.1016\/j.ejmg.2021.104312_bib12","doi-asserted-by":"crossref","first-page":"D835","DOI":"10.1093\/nar\/gkz972","article-title":"Improvements to accessing data","volume":"48","author":"Landrum","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.ejmg.2021.104312_bib13","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0968-0004(98)01208-0","article-title":"A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance","volume":"23","author":"Nagy","year":"1998","journal-title":"Trends Biochem. Sci."},{"issue":"5","key":"10.1016\/j.ejmg.2021.104312_bib14","doi-asserted-by":"crossref","first-page":"1902443","DOI":"10.1183\/13993003.02443-2019","article-title":"Re-imagining cystic fibrosis care: next generation thinking","volume":"55","author":"Rang","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.ejmg.2021.104312_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"issue":"17","key":"10.1016\/j.ejmg.2021.104312_bib16","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1182\/blood.2019004560","article-title":"Mutational and phenotypic characterisation of hereditary hemorrhagic telangiectasia","volume":"136","author":"Shovlin","year":"2020","journal-title":"Blood"}],"container-title":["European Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721221001786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721221001786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:50:39Z","timestamp":1761709839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769721221001786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1769721221001786"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmg.2021.104312","relation":{},"ISSN":["1769-7212"],"issn-type":[{"value":"1769-7212","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA variant classification\u2013reconsidering \u201callele rarity\u201d and \u201cphenotype\u201d criteria in ACMG\/AMP guidelines","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medical Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmg.2021.104312","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"104312"}}